Adverum Biotechnologies, Inc. (ADVM)

4.36 0.00 (0.00%) USD  |  NASDAQ  |  Jan 21, 16:00
More

Adverum Biotechnologies Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for ADVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Pfizer Inc. --
Recursion Pharmaceuticals, Inc. Upgrade
Quantum-Si, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade